martes, 25 de julio de 2017

Announcing the HPV Vaccine is Cancer Prevention Champion Award

vax news

The HPV Vaccine is Cancer Prevention Champion Award:

mark 2
The Centers for Disease Control and Prevention (CDC), the Association of American Cancer Institutes (AACI), and the American Cancer Society (ACS) are partnering to recognize immunization providers who are successfully preventing HPV cancers, through timely vaccination of their young adolescent patient population.
The program will serve to motivate clinicians to adopt effective recommendation practices, and help educate clinicians on the individual- and practice-level changes that can improve rates. By recognizing clinicians with high HPV vaccine rates, we hope the program also serves to reinforce for parental audiences that HPV vaccination is an important part of cancer prevention and a normal part of adolescent immunization.

Who Can be Nominated?

Clinicians, clinics, practices, groups, and/or health systems can be nominated for the HPV Vaccine Is Cancer Prevention Champion Award if they are effectively working to protect their adolescent patients against HPV cancers by achieving high HPV vaccination completion rates. Each year, the award program will honor up to one Champion from each of the 10 U.S. Department of Health and Human Services (HHS) regions.
 Champions will be selected based on the following criteria and considerations:
  • Nominee must be a clinician, clinic, practice, group, or health system
  • Nominee must reach target series completion rate of 70% for the patient population aged 13–15 years. The rate must account for both female and male patients. Vaccination under the two-dose schedule (two doses given at least five months apart in children ages 9–14 years) satisfies series completion, as does the original three--‐dose schedule.
  • Patient population size will be considered. Patient population is defined as patients who have had a clinical encounter with the nominee in the previous 24 months.
  • Data provided via AFIX (Assessment, Feedback, Incentives, and eXchange) can be used for nomination. Other data sources can include immunization information systems, electronic health record platforms, quality improvement initiatives, or performance measure systems, but that data must be validated by the state or local immunization.
  • Submissions must be received by September 15, 2017.

How Are Winners Selected?

Once submissions are received, a CDC review panel will evaluate all nominations. The panel will select up to one awardee from each of the 10 HHS regions based on the listed criteria and considerations. AACI and ACS will approve each awardee selection, and then, the organizations will co-issue the awards. Champions will be announced in October 2017. 

How will Champions be Recognized?

Champions will be featured on CDC’s website and in the #PreteenVaxNews e-newsletter, will receive an HPV Vaccine Is Cancer Prevention Champion plaque, and may be recognized at local or national events led by cancer prevention or pediatric health organizations.

materials 2
Want to know more? Learn more about the HPV Vaccine is Cancer Prevention Champion Award and nominate a Champion today at

No hay comentarios:

Publicar un comentario